Independent product information • Affiliate-supported • Last updated
Independent EndoPeak research

EndoPeak Ingredients: Complete Formula & Ingredient Guide

The current label lists nine active nutrients and botanicals. This guide separates those label facts from what independent research can—and cannot—support.

Reviewed and updated: September 12, 2026
Label facts Ingredient identities and amounts below come from the supplied current product label. Independent research Evidence summaries are discussed separately.
EndoPeak supplement bottle and ingredient label

Formula overview

EndoPeak's current two-capsule serving contains two minerals and seven botanicals. Marketing language commonly groups some botanicals around male vitality or performance, but the label itself does not establish clinical outcomes.

Complete ingredient list and amounts

Magnesium
133.3 mg

Magnesium oxide · research guide

Zinc
20 mg

Zinc oxide · research guide

Tribulus (fruit)
500 mg

Tribulus terrestris · research guide

Chrysin
50 mg

Oroxylum indicum · research guide

Epimedium (aerial parts)
33.3 mg

Epimedium sagittatum · research guide

Tongkat Ali (root)
33.3 mg

Eurycoma longifolia · research guide

Saw Palmetto berries
33.3 mg

Serenoa repens · research guide

Chinese Hawthorn berry
33.3 mg

Crataegus pinnatifida · research guide

Winged Treebine (stem)
33.3 mg

Cissus quadrangularis · research guide

Magnesium and zinc

Magnesium contributes to many normal biochemical processes, including muscle and nerve function. Zinc is involved in numerous enzymes and biological processes. Those established nutrient roles should not be stretched into a claim that EndoPeak treats sexual dysfunction or raises testosterone in every user. The specific forms listed are magnesium oxide and zinc oxide.

Seven botanical ingredients

Tribulus terrestris — 500 mg

Tribulus is common in male-performance supplements. Human trials and reviews have produced mixed findings depending on population and outcome. A study of an ingredient is not a study of the complete EndoPeak formula.

Chrysin — 50 mg

Chrysin is a flavonoid often marketed in hormone-support contexts. Human pharmacokinetic research has reported low oral bioavailability, and a small human study did not find a change in urinary testosterone with a chrysin-containing preparation. That makes strong testosterone-boosting promises especially inappropriate.

Epimedium — 33.3 mg

Epimedium species contain compounds including icariin that have been studied in laboratory, animal and limited human contexts. Reviews discuss biological mechanisms, but mechanism-level research does not establish that EndoPeak has a clinical erectile-function effect.

Tongkat Ali — 33.3 mg

Tongkat Ali has human studies and meta-analyses in selected populations. Products, extracts and doses differ, however, so findings cannot simply be transferred to this formula.

Saw Palmetto — 33.3 mg

Saw palmetto has been studied extensively for urinary/prostate symptoms. NCCIH notes that saw palmetto alone is probably not helpful for symptoms of benign prostatic hyperplasia and that evidence for other uses is insufficient.

Chinese Hawthorn — 33.3 mg

Hawthorn has a history of use in cardiovascular contexts, but NCCIH emphasizes limitations in the evidence and notes possible adverse effects and interactions.

Winged Treebine / Cissus quadrangularis — 33.3 mg

Cissus quadrangularis has been studied for several possible uses. Systematic reviews emphasize the need to interpret small, heterogeneous studies carefully.

What ingredient evidence can and cannot tell us

Evidence boundary: We did not identify a peer-reviewed randomized controlled trial of the finished EndoPeak formula during this build. Accordingly, this site does not call EndoPeak “clinically proven.” Ingredient evidence is presented as background, not finished-product proof.

References

  1. NIH ODS — Magnesium
  2. NIH ODS — Zinc
  3. NCCIH — Saw Palmetto
  4. NCCIH — Hawthorn
  5. Tribulus systematic review — PubMed-indexed review.
  6. Tongkat Ali meta-analysis — PubMed-indexed meta-analysis.
  7. Chrysin disposition in humans — Human pharmacokinetic research.
  8. Cissus quadrangularis systematic review — PubMed-indexed systematic review.
  9. Epimedium/icariin review — Mechanistic and clinical-context review.